Abstract | PURPOSE: METHODS: Randomly [¹¹C] methylated LY2181308 was produced with [¹¹C] methyl iodide. The biodistribution was performed in female Sprague-Dawley (SD) rats and EMT-6 tumor-bearing mice in the presence of nonradioactive LY2181308. Human dosimetry calculations were based on baboon PET studies. RESULTS: In SD rats, the kidney and liver were the organs with the most accumulation of radioactivity. Tumor uptake in mice was also relatively high after 5 min and remained constant for up to 1 h. Baboon dosimetry suggested that up to 42 mCi of radioactivity could be administered to human with a dose-limiting organ being the kidneys with a radiation dose of 32 µGy/MBq (0.118 rad/mCi). CONCLUSIONS: [¹¹C] methylated LY2181308 to rodents and baboons showed its biodistribution, tumor uptake, and human dosimetry evaluation. These results should facilitate the understanding of the pharmacokinetics of LY2181308 prior to use as a potential new therapeutic agent in oncology as well as to warrant more in vivo validations as a potentially useful tumor-imaging agent.
|
Authors | Carmen S Dence, Richard Laforest, Xiankai Sun, Terry L Sharp, Michael J Welch, Robert H Mach |
Journal | Molecular imaging and biology
(Mol Imaging Biol)
Vol. 12
Issue 6
Pg. 608-15
(Dec 2010)
ISSN: 1860-2002 [Electronic] United States |
PMID | 20376567
(Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carbon Radioisotopes
- LY 2181308
- Oligonucleotides
- Radiopharmaceuticals
|
Topics |
- Adult
- Animals
- Carbon Radioisotopes
(administration & dosage, pharmacokinetics)
- Female
- Humans
- Male
- Mice
- Mice, Inbred BALB C
- Neoplasms
(diagnostic imaging, metabolism)
- Oligonucleotides
(administration & dosage, pharmacokinetics)
- Papio
- Radiation Dosage
- Radiometry
(methods)
- Radionuclide Imaging
- Radiopharmaceuticals
(administration & dosage, chemical synthesis, pharmacokinetics)
- Rats
- Rats, Sprague-Dawley
- Rodentia
(metabolism)
- Tissue Distribution
|